Latest revenue
$705.5M
as of 2026-04-03
Latest net income
$38.7M
as of 2026-04-03
Net margin
5.5%
as of 2026-04-03
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $3.81B
- Enterprise value
- $3.81B
- P/E (trailing)
- 81.1×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $30.42
- 52-wk low
- $17.03
- Beta
- —
- Shares out
- 162.7M
5-year trend
What this company does
ITEM 1. BUSINESS Overview Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. We help our customers deliver the best possible patient care through industry-leading products, solutions, and technology. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the human smile. We further support the dental community with leading solutions in restoratives,…
AI summary unavailable — showing raw filing excerpt
Generated from NVST's filing dated 2026-02-12
Key risks
ITEM 1A. RISK FACTORS You should carefully consider the risks and uncertainties described below, together with the information included elsewhere in this Annual Report on Form 10-K and other documents we file with the SEC. The risks and uncertainties described below are those that we have identified as material, but are not the only risks and uncertainties facing us. Our business is also subject to general risks and uncertainties that affect many other companies, such as market conditions, economic conditions, geopolitical events, changes in laws, regulations or accounting rules, fluctuations in interest rates, terrorism, wars or conflicts, major health concerns, natural disasters or other…
AI summary unavailable — showing raw filing excerpt
Generated from NVST's filing dated 2026-02-12
Profitability
Gross margin
54.7%
0.0%Operating margin
7.9%
119.2%Net margin
1.7%
103.9%Return on equity
1.6%
106.0%Return on assets
0.8%
104.0%Leverage
Debt / equity
0.94×
231.7%Long-term debt / equity
0.49×
61.1%Debt / assets
48.3%
119.7%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q2 2026 2026-04-03 | $705.5M | +14.4% | $38.7M | +115.0% | 5.5% |
Q4 2025 2025-12-31 | $750.6M | +15.0% | $-11.5M | +48.7% | -1.5% |
Q3 2025 2025-09-26 | $669.9M | +11.5% | $14.1M | +72.0% | 2.1% |
Q2 2025 2025-06-27 | $682.1M | +7.7% | $26.4M | +102.3% | 3.9% |
Q1 2025 2025-03-28 | $616.9M | -1.1% | $18.0M | -23.7% | 2.9% |
Q4 2024 2024-12-31 | $652.9M | — | $-22.4M | — | -3.4% |
Q3 2024 2024-09-27 | $601.0M | -4.8% | $8.2M | -61.9% | 1.4% |
Q2 2024 2024-06-28 | $633.1M | -4.4% | $-1.13B | -2273.4% | -178.2% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Dental Equipment & Supplies · SIC 3843
Your notes
Keep private notes on NVST — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$614.3K
Net activity
−$614.3K
Distinct insiders
1
Open-market trades over the last 365 days.
Recent transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| 2026-02-10 | Mischa Reis SVP, Strategy & Bus. Dev. | Sale | 4,041 | $30.00 | $121.2K | |
| 2026-02-10 | Mischa Reis SVP, Strategy & Bus. Dev. | Sale | 5,634 | $30.00 | $169.0K |
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns NVST
Institutional value
$1.97B
Total shares held
78.4M
Distinct holders
241
-90 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 17.9M | $452.9M | +313.5K (+1.8%) | Added |
| 2 | DIMENSIONAL FUND ADVISORS LP | 9.8M | $248.1M | +152.5K (+1.6%) | Added |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 7.6M | $192.0M | — | New |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 7.3M | $185.7M | — | New |
| 5 | FRANKLIN RESOURCES INC | 6.9M | $174.9M | -1.2M (-14.5%) | Trimmed |
| 6 | JPMORGAN CHASE & CO | 2.9M | $70.7M | -715.7K (-19.7%) | Trimmed |
| 7 | PZENA INVESTMENT MANAGEMENT LLC | 1.6M | $40.7M | -721.7K (-31.0%) | Trimmed |
| 8 | Invesco Ltd. | 1.5M | $38.4M | -33.7K (-2.2%) | Trimmed |
| 9 | Tweedy, Browne Co LLC | 1.4M | $36.5M | -6.6K (-0.5%) | Trimmed |
| 10 | JUPITER ASSET MANAGEMENT LTD | 1.4M | $35.1M | -617.2K (-30.9%) | Trimmed |
| 11 | Bank of New York Mellon Corp | 1.3M | $32.9M | -13.7K (-1.0%) | Trimmed |
| 12 | Varenne Capital Partners | 1.1M | $26.7M | — | New |
| 13 | VANGUARD FIDUCIARY TRUST CO | 1.0M | $25.9M | — | New |
| 14 | ROYCE & ASSOCIATES LP | 978.4K | $24.8M | -17.7K (-1.8%) | Trimmed |
| 15 | Russell Investments Group, Ltd. | 914.1K | $23.2M | +807.7K (+759.5%) | Added |
| 16 | UBS Group AG | 781.0K | $19.8M | +219.7K (+39.2%) | Added |
| 17 | Capricorn Fund Managers Ltd | 746.2K | $18.9M | — | New |
| 18 | Marathon Asset Management Ltd | 723.2K | $18.3M | +85.7K (+13.4%) | Added |
| 19 | JANE STREET GROUP, LLC | 639.9K | $16.2M | — | New |
| 20 | SEI INVESTMENTS CO | 632.0K | $16.0M | +212.9K (+50.8%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once NVST's latest filing finishes processing.